Clinical Trial Update: FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying FOLFIRINOX with elraglusib and losartan in pancreatic adenocarcinoma, including metastatic disease. The study is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Elraglusib (elraglusib)
• FOLFIRINOX
• Losartan (losartan)

Snippet

Sponsor: Colin D. Weekes, M.D., PhD | Conditions: Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING